This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Master Pharm Management
Management criteria checks 1/4
Key information
Jacek Franasik
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 19.9yrs |
| CEO ownership | 71.8% |
| Management average tenure | no data |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27CEO
Jacek Franasik
19.9yrs
Tenure
zł859,623
Compensation
Mr. Jacek Franasik has been President of Management Board and Partner of Master Pharm SA since October 25, 2002. Mr. Franasik served as Chief Commercial Officer at Agropharm S.A. from 1999 to 2003. He has...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of Supervisory Board | 7.2yrs | zł25.39k | no data | |
| Independent Vice Chairman of Supervisory Board | 7.2yrs | zł12.70k | no data | |
| Member of Supervisory Board | 7yrs | zł12.70k | no data |
7.2yrs
Average Tenure
Experienced Board: MPH's board of directors are considered experienced (7.2 years average tenure).